Icon

AREDIA (nda020036)- (30MG/VIAL,60MG/VIAL,90MG/VIAL)

PAMIDRONATE DISODIUM NOVARTIS
30MG/VIAL,60MG/VIAL,90MG/VIAL
Yes No
2005-Jul-29 Expired
None None
None No
Aredia, in conjunction with adequate hydration, is indicated for the treatment of moderate or severe hypercalcemia associated with malignancy, with or without bone metastases. Aredia is indicated for the treatment of patients with moderate to severe Paget’s disease of bone.
5 0 3
Total Other Developers None
Drugs with Suitability No
30MG/VIAL ** ** - - -
60MG/VIAL ** ** - - -
90MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ******* ******* ********* *** *** *********** *-** ***** **, ********, ******** ****, ********* (***) ***
****** ******* ****** ****** *******, ***. *** *********** **** ******** *****, *******, ******** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************ ******* *********** (***), **** **. ***-*, *********** ****** **** ****, ********** ****, ****** *****, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.